TNXP · Tonix Pharmaceuticals Holding Corp.
AI read · Bad for TNXP
The AI's read
A generic rival could take sales from TONMYA if it reaches patients. Tonix says it will defend its patents, and a timely lawsuit could delay FDA approval. But that delay is not guaranteed, and the case could still end against Tonix.